Brief: Implantica Q4 EBIT Rises To EUR 5.1 Mln
17/02/2023 07:14
Feb 17 (Reuters) - Implantica AG 8IM1q.F :
* Q4 NET SALES INCREASED 126% TO TEUR 242 (107)
* Q4 ADJUSTED GROSS MARGIN AMOUNTED TO 96% (91%)
* Q4 EBIT INCREASED TO TEUR 5,108 (3,990)
Source text for Eikon: ID:nWkr5Lj0z5
Further company coverage: 8IM1q.F
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Implantica AG
See all newsBrief: Implantica Q1 Operating Loss At EUR 3.9 Mln
Brief: Implantica Gives Final Response To FDA For PMA Application
Brief: Implantica Announces Adoption Of Refluxstop At Careggi University Hospital
Brief: Implantica - FDA Provides Feedback On Refluxstop PMA Module 3
Brief: Implantica Says FDA Provides Favorable Feedback On Refluxstop Pma Module 3